IMAX 8-K SEC Filing Analysis

Latest settled — T+20d

IMAX ▲ +10.90% at T+20d

NEUTRAL call ✓ call won +10.90% · α vs SPY +5.62% · entry $36.51 → $40.49

Next anchor: T+60d in 7w

Currently $40.11 · +9.86% from $36.51 entry

Entry anchored
Apr 30, 03:59 PM ET
via Databento tick

T+1d

-3.48%

call -3.48% · α -3.14%

$35.24

settled 6w ago

T+5d

-2.38%

call -2.38% · α -4.73%

$35.64

settled 5w ago

T+20d

+10.90%

call +10.90% · α +5.62%

$40.49

settled 12d ago

T+60d

—

call — · α —

—

in 7w

Price Chart

Loading chart...

Executive Summary

IMAX reported Q1 2026 results with total revenue of $81.4M, down 6% YoY, and GAAP diluted EPS of $0.07, up 75% YoY. The headline revenue decline was driven by a tough comp against the record Chinese New Year box office in Q1 2025, but adjusted EPS of $0.17 beat the $0.15 consensus and the company reaffirmed its full-year 2026 guidance for $1.4B in global box office.

Key Financial Metrics

Free Cash Flow

-$2.9M

Gross Margin

56.3%

Actionable Insight

The revenue miss on a tough China comp is largely discounted given the strong slate ahead (The Odyssey, Dune Part Three). The adjusted EPS beat and reaffirmed full-year guidance should support the stock near term. Watch for Q2 box office momentum from these tentpole releases as the key catalyst.

Key Facts

Q1 2026 total revenue of $81.4M, down 6% YoY from $86.7M
GAAP diluted EPS of $0.07, up 75% YoY from $0.04
Adjusted diluted EPS of $0.17, up 31% YoY from $0.13
Net income attributable to common shareholders of $4.2M, up 83% YoY from $2.3M
Global box office of $260M, down 13% YoY due to China weakness
Reaffirmed 2026 full-year guidance of $1.4B in global box office
Content Solutions revenue down 8% YoY; Technology Products & Services revenue down 4% YoY
Operating cash flow of $4M vs $7M in prior year period
42 system signings across 10 countries YTD, including largest Australia agreement

Financial Impact

Revenue declined 6% YoY to $81.4M, but adjusted EPS of $0.17 beat consensus of $0.15 by 13.3%

revenueepsgross marginoperating cash flow

Risk Factors

Greater China box office weakness may persist if local language titles shift further into 2026
CEO medical leave introduces leadership uncertainty despite gradual return
Gross margin contracted 510 bps YoY to 56.3%, signaling cost pressure

Market Snapshot

Exchange

NYSE

Sector

Photographic Equipment & Supplies

Analyst Consensus

89% bullish (18 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001628280-26-028907
Document: imax-20260430.htm	0001628280-26-028907
Document: 0001628280-26-028907-index-headers.html	0001628280-26-028907
Document: 0001628280-26-028907-index.html	0001628280-26-028907
Document: 0001628280-26-028907.txt	0001628280-26-028907
8-K Data (Synthetic)	0001628280-26-028907

4 reports for IMAX

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for IMAX — sortable, filterable
	Type				Now
Apr 30, 2026 5w ago	8-K MIXED ★ 5/10	$36.51 $40.49	▲ +10.90%	▲ +5.62%	$40.11 (+9.86%)
Apr 17, 2026 7w ago	8-K NEUTRAL ★ 3/10	$35.95 $34.25	▼ −4.73%	▼ −8.93%	$40.11 (+11.57%)
Mar 10, 2026 13w ago	Insider Cluster BEARISH ★ 7/10	$39.71 $38.20	▲ +3.80%	▲ +3.65%	$40.11 (−1.01%)
Feb 25, 2026 14w ago	8-K BULLISH ★ 8/10	$41.77 $37.75	▼ −9.62%	▼ −3.22%	$40.11 (−3.97%)

US Market Status

Market Closed — Opens Thu (10h 58m)

Related Tickers

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access